ALIGN TECHNOLOGY INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $189.7m $231.4m $400.2m $442.8m $1.8b $772.0m $361.6m $445.1m $421.4m $410.4m
Depreciation, Depletion and Amortization $24.0m $37.7m $54.7m $79.0m $93.5m $108.7m $125.8m $142.4m $145.0m $237.4m
Depreciation $24.0m $37.7m $54.7m $79.0m $93.5m $92.1m $109.8m $126.0m $126.2m $218.6m
Amortization of Intangible Assets $6.0m $5.9m $13.4m $16.6m $16.0m $16.4m $18.9m $18.8m
Deferred Income Tax Expense (Benefit) ($16.4m) $17.6m ($15.7m) $307k ($1.5b) $15.5m ($39.5m) ($18.6m) $25.8m $33.1m
Share-based Payment Arrangement, Noncash Expense $54.1m $58.9m $70.8m $88.2m $98.4m $114.3m $133.4m $154.0m $173.7m $185.9m
Payment, Tax Withholding, Share-based Payment Arrangement $29.9m $46.2m $86.1m $57.7m $51.1m $108.9m $52.8m $22.6m $28.1m $20.4m
Share-based Payment Arrangement, Expense $54.1m $58.9m $70.8m $88.2m $98.4m $114.3m $133.4m $154.0m $173.7m $185.9m
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount $5.9m $0 $5.0m ($5.9m) ($18.1m)
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($23.0m) $0 $0 $0 $0 $23.1m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0
Equity Method Investment, Realized Gain (Loss) on Disposal $15.8m $0 $0
Income (Loss) from Equity Method Investments ($1.7m) ($3.2m) ($8.7m) ($7.5m) $0 $0
Income Tax Expense (Benefit) $51.2m $130.2m $57.7m $112.3m ($1.4b) $240.4m $237.5m $196.2m $187.6m $174.9m
Operating Lease, Lease Income $12.3m $16.6m $21.7m $28.8m
Other Nonoperating Income (Expense) ($6.4m) $11.2m ($8.5m) $7.7m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $94.4m $91.0m $109.2m $121.0m $139.8m $262.1m ($21.5m) $104.6m $153.5m $139.9m
Increase (Decrease) in Inventories $7.7m $5.5m $24.1m $58.3m $29.1m $112.5m $130.1m ($30.2m) ($25.1m) ($808k)
Increase (Decrease) in Accounts Payable ($3.4m) $8.2m $25.0m $22.1m $52.2m $19.7m ($36.5m) ($7.7m) ($843k) $5.3m
Foreign Currency Transaction Gain (Loss), Realized ($8.0m) $9.0m ($5.6m) ($2.0m) $6.8m ($13.3m) ($43.8m) ($7.0m) ($21.0m) $11.3m
Gain (Loss) on Termination of Lease $0 $0
Gain (Loss) Related to Litigation Settlement $51.0m $0 $0 $0 $0 ($31.0m) ($4.2m)
Goodwill $61.0m $64.6m $64.0m $63.9m $444.8m $418.5m $407.6m $419.5m $442.6m $491.8m
Inventory Write-down $14.9m
Nonoperating Income (Expense) ($11.3m) $32.9m ($48.9m) ($19.4m) ($18.9m) $23.5m
Operating Expenses $566.4m $763.3m $981.3m $1.2b $1.4b $2.0b $2.0b $2.1b $2.2b $2.2b
Net Cash Provided by (Used in) Operating Activities $247.7m $438.5m $554.7m $747.3m $662.2m $1.2b $568.7m $785.8m $738.2m $593.2m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $70.6m $195.7m $223.3m $149.7m $154.9m $401.1m $291.9m $177.7m $115.6m $102.4m
Payments to Acquire Businesses, Net of Cash Acquired $9.0m $0 $0 $420.8m $8.0m $12.3m $0 $77.1m $0
Payments for (Proceeds from) Other Investing Activities $8.2m ($567k) ($765k) $14.7m ($1.2m) $5.0m $2.2m ($278k) ($235k) $0
Net Cash Provided by (Used in) Investing Activities $72.8m ($248.3m) $6.9m ($350.4m) ($231.5m) ($563.4m) ($213.3m) ($195.9m) ($254.9m) ($112.4m)
Cash flows from financing activities:
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $42.6m $498k $23.8m $55.2m $25.7m $0
Proceeds from Issuance of Common Stock $13.8m $14.5m $16.6m $17.9m $20.3m $25.6m $26.1m $26.6m $25.3m $21.7m
Payments for Repurchase of Common Stock $96.2m $103.8m $300.0m $400.0m $0 $375.0m $435.0m $592.4m $352.9m $465.9m
Net Cash Provided by (Used in) Financing Activities ($95.5m) ($135.5m) ($369.4m) ($485.5m) ($30.8m) ($458.3m) ($501.7m) ($598.3m) ($355.7m) ($464.6m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($3.4m) $5.5m ($4.7m) $2.3m $10.5m ($12.1m) ($11.5m) $4.7m ($21.2m) $35.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($3.4m) $5.5m $187.4m ($86.4m) $410.3m $138.7m ($157.8m) ($3.8m) $106.4m $51.2m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($3.4m) $5.5m $637.6m $551.1m $961.5m $1.1b $942.4m $938.5m $1.0b $1.1b
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net ($29.9m) ($46.2m) ($86.1m) ($57.7m) ($51.1m) ($108.9m) ($52.8m) ($22.6m) ($28.1m) $134.8m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.